Company Profiles

driven by the PitchBook Platform

Avelas Biosciences

Description

Operator of a biotechnology company intended to design standard-of-care for cancer surgery and therapeutic intervention. The company's technology allows real time diagnosis of metastatic nodes using proprietary platform technology of activatable cell-penetrating peptides enabling patients a faster cure from cancer.

2009

Founded

PRIVATE

Status

11-50

Employees

Corporate

Latest Deal Type

$2.5M

Latest Deal Amount

$37.6M

Total Amount Raised

Description

Operator of a biotechnology company intended to design standard-of-care for cancer surgery and therapeutic intervention. The company's technology allows real time diagnosis of metastatic nodes using proprietary platform technology of activatable cell-penetrating peptides enabling patients a faster cure from cancer.

Website:

www.avelasbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Surgical Devices
Diagnostic Equipment

Primary Office

11099 North Torrey Pines Road Suite 180, La Jolla San Diego, CA 92037United States +1 (858) 750-4700
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Avelas Biosciences's full profile, request a free trial.

    Avelas Biosciences Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Avelas Biosciences Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Avelas Biosciences Investors (9)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Alexandria Real Estate EquitiesReal EstateMinority000 0000000 0000
    Avalon VenturesVenture CapitalMinority000 0000000 0000
    Bregua CorporationOtherMinority000 0000000 0000
    Ervington InvestmentsVenture CapitalMinority000 0000000 0000
    Inbio VenturesVenture CapitalMinority000 0000000 0000
    Alexandria Real Estate Equities Real Estate
    Avalon Ventures Venture Capital
    Bregua Corporation Other
    Ervington Investments Venture Capital
    Inbio Ventures Venture Capital

    Avelas Biosciences Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Carmine StengoneChief Executive Officer, President and Board Member
    Jesus Gonzalez Ph.DChief Scientific Officer
    Kevin KinsellaCo-Founder
    Roger Tsien Ph.DCo-Founder and and Research Collaborator
    Steven Chen MDChief Medical Officer
    Carmine Stengone Chief Executive Officer, President and Board Member
    Jesus Gonzalez Ph.D Chief Scientific Officer
    Kevin Kinsella Co-Founder
    Roger Tsien Ph.D Co-Founder and and Research Collaborator
    Steven Chen MD Chief Medical Officer

    Avelas Biosciences Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Alexey Vinogradov Ph.DInbio VenturesChief Business Officer & Managing Partner000 0000
    Andrei Petrov Ph.DInbio VenturesFounder, Chief Executive Officer & Managing Partner000 0000
    Carmine StengoneAvelas BiosciencesChief Executive Officer, President and Board Member000 0000
    Claus Kremoser Ph.DSelfBoard Member000 0000
    Jay Lichter Ph.DAvalon VenturesManaging Director, Entrepreneur & Partner000 0000
    Alexey Vinogradov Ph.D Chief Business Officer & Managing Partner Inbio Ventures
    Andrei Petrov Ph.D Founder, Chief Executive Officer & Managing Partner Inbio Ventures
    Carmine Stengone Chief Executive Officer, President and Board Member Avelas Biosciences
    Claus Kremoser Ph.D Board Member Self
    Jay Lichter Ph.D Managing Director, Entrepreneur & Partner Avalon Ventures
    Request full access to PitchBook